Investors Snag ACAD 15.2% Cheaper Than Its Secondary Stock Offering
November 09, 2016 at 09:58 AM EST
Looking back to 92 days ago, Acadia Pharmaceuticals Inc (ACAD) priced a 6,060,606 share secondary stock offering at $33.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..